为患有慢性疼痛的人开发阿片类污名度量表
Lisa R Carnago1, Mirlene Perry2, Brandon A Knettel3
1Department of Medicine, Division of Rheumatology and Immunology, Duke University, School of Medicine, Durham, NC; Duke University, School of Nursing, Durham, NC.
概括
这项研究引入了一种新的13项尺度,用于测量慢性疼痛患者的阿片类污名,评估感知和内化污名. 该尺度显示出良好的可靠性和有效性,有助于理解和解决患者的经验.
科学领域:
- 心理学 心理学 心理学
- 医学社会学 医学社会学
- 疼痛管理 疼痛管理
背景情况:
- 耻辱严重影响慢性疼痛患者的心理健康.
- 现有的污名化措施无法充分解决该人口中阿片类药物特定的污名化问题.
- "阿片类药物耻辱"是慢性疼痛需要阿片类药物治疗的个体的关键问题.
研究的目的:
- 开发和验证一种评估慢性疼痛患者中阿片类药物污名的新方法.
- 区分感知的耻辱 (外部态度) 和内化的耻辱 (自我感知).
- 提供可靠的工具来量化慢性疼痛群体中阿片类药物污名的数量.
主要方法:
- 一个由13项组成的尺度是从对慢性疼痛患者的现有耻辱度量来调整的.
- 参与者 (N=151) 完成了适应的尺度,以及抑郁症,自尊和弹性等措施.
- 用统计分析评估了心理测量特性,包括因子结构,可靠性和有效性.
主要成果:
- 一个由两个因素组成的结构出现了,区分感知和内化阿片类药物污名.
- 该尺度表现出高的内部一致性 (两个因素的α = .94).
- 感知到的耻辱与抑郁症相关,内化耻辱与较低的弹性相关.
结论:
- 13项阿片类药物污名度表具有良好的心理测量特性,用于评估感知和内化污名.
- 这项经过验证的措施可以帮助研究人员和临床医生了解阿片类药物污名对慢性疼痛患者的影响.
- 护士可以利用这个工具来识别和干预阿片类污名的病例,改善患者的护理.
相关概念视频
Analgesia and Pain Management
1.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.4K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
875
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
875
Opioid Analgesics: Morphine and Other Natural Cogeners
797
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
797
Opioid Receptors: Overview
3.9K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
3.9K
Nociception
32.9K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
32.9K
Drug Abuse and Addiction: Pharmacological Phenomena
1.1K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.1K


